DULUTH, Ga., Sept. 15, 2020 /PRNewswire/ -- Boehringer Ingelheim today announced the U.S. launch of the Aservo® EquiHaler® (ciclesonide inhalation spray), the first FDA-approved inhalant therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results